Tags

Type your tag names separated by a space and hit enter

Liquid and Foam Sclerotherapy for Spider and Varicose Veins.
Surg Clin North Am. 2018 Apr; 98(2):415-429.SC

Abstract

Sclerotherapy has wide applicability in treating venous disease at every stage of clinical disease. The various sclerosant drugs and formulations each have unique properties, utilities, and side effects. Treating physicians should be aware of the differences between agents, accounting for disease presentation, vein characteristics, and patient comorbidities when selecting the appropriate sclerosing agents. Successful outcomes rely on proper patient evaluation and assessment for contraindications to sclerotherapy. Thorough patient education regarding realistic expectations with sclerotherapy in terms of symptoms relief, recurrence, and improvement in appearance is of chief importance.

Links

Publisher Full Text
linkinghub.elsevier.com
journals.elsevierhealth.com
Aggregator Full Text

Authors+Show Affiliations

Gibson K
Lake Washington Vascular Surgeons, 1135 116th Avenue Northeast, Suite 305, Bellevue, WA 98004, USA. Electronic address: drgibson@lkwv.com.
Gunderson K
Lake Washington Vascular Surgeons, 1135 116th Avenue Northeast, Suite 305, Bellevue, WA 98004, USA.

MeSH

Dosage FormsHumansSclerosing SolutionsSclerotherapyTelangiectasisTreatment OutcomeVaricose Veins

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

29502781

Citation

Gibson, Kathleen, and Krissa Gunderson. "Liquid and Foam Sclerotherapy for Spider and Varicose Veins." The Surgical Clinics of North America, vol. 98, no. 2, 2018, pp. 415-429.
Gibson K, Gunderson K. Liquid and Foam Sclerotherapy for Spider and Varicose Veins. Surg Clin North Am. 2018;98(2):415-429.
Gibson, K., & Gunderson, K. (2018). Liquid and Foam Sclerotherapy for Spider and Varicose Veins. The Surgical Clinics of North America, 98(2), 415-429. https://doi.org/10.1016/j.suc.2017.11.010
Gibson K, Gunderson K. Liquid and Foam Sclerotherapy for Spider and Varicose Veins. Surg Clin North Am. 2018;98(2):415-429. PubMed PMID: 29502781.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Liquid and Foam Sclerotherapy for Spider and Varicose Veins. AU - Gibson,Kathleen, AU - Gunderson,Krissa, Y1 - 2017/12/22/ PY - 2018/3/6/entrez PY - 2018/3/6/pubmed PY - 2018/3/15/medline KW - Foam sclerotherapy KW - Sclerotherapy KW - Spider veins KW - Telangiectasia KW - Varicose veins SP - 415 EP - 429 JF - The Surgical clinics of North America JO - Surg Clin North Am VL - 98 IS - 2 N2 - Sclerotherapy has wide applicability in treating venous disease at every stage of clinical disease. The various sclerosant drugs and formulations each have unique properties, utilities, and side effects. Treating physicians should be aware of the differences between agents, accounting for disease presentation, vein characteristics, and patient comorbidities when selecting the appropriate sclerosing agents. Successful outcomes rely on proper patient evaluation and assessment for contraindications to sclerotherapy. Thorough patient education regarding realistic expectations with sclerotherapy in terms of symptoms relief, recurrence, and improvement in appearance is of chief importance. SN - 1558-3171 UR - https://www.unboundmedicine.com/medline/citation/29502781/Liquid_and_Foam_Sclerotherapy_for_Spider_and_Varicose_Veins_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0039-6109(17)30218-9 DB - PRIME DP - Unbound Medicine ER -